XKRX
090430
Market cap4.47bUSD
Jul 09, Last price
116,300.00KRW
1D
-6.44%
1Q
-11.83%
Jan 2017
-63.83%
IPO
-88.37%
Name
AmorePacific Corp
Chart & Performance
P/E
89.66
P/S
4.97
EPS
1,297.17
Div Yield, %
—
Shrs. gr., 5y
1.13%
Rev. gr., 5y
-0.82%
Revenues
4.25t
+9.46%
Net income
235.68b
-60.27%
CFO
583.84b
+74.54%
Dividend
Dec 27, 2023910 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Amorepacific Corporation, established in 1945 and headquartered in Seoul, South Korea, is a global enterprise dedicated to the development, production, and distribution of beauty, household, and healthcare merchandise. Its comprehensive product portfolio features a wide array of skincare solutions, including daily cleansers, toners, fluids, and moisturizers, alongside specialized eye care treatments, potent serums, facial masks, and convenient special care and travel-sized offerings. The company further addresses consumer needs with formulations targeting anti-aging, dryness, enhancements in skin tone and texture, sun protection, and a complete line of cosmetic products.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||